Latest: Watch here for details of new products and services.
- Our Products
- Overview
- Partnering Search
- Company Profiling
- Partneringtools
- Reports
- Partnering Consulting
- Comparison
- Forums
- Visit our forums
- Jobs
- Visit our job site
- Case Studies
- See what others think about our service
- Newsletter
- Partnering update
- Key reports
- Subscribe
- Quick Links
- Profile now
- Register now
- Profiled companies
- Featured events
- Industry news
- PR Newswire New!
- Contact us
- Send an email
- Call us: +44 1904 520460
- Request a callback
- RSS Feeds
- Keep up to date
Pharmalicensing Ltd
is a division of
is a division of
- Companies
- Company details
Bridgehead International Limited
A globally recognized provider of consultancy, medical education and business information services to support extraordinary company and product growth in the healthcare sectorThe company in detail
Profile
A globally recognized provider of consultancy, medical
education and business information services to support
extraordinary company and product growth in the healthcare
sector.
Bridgehead International is a leading biopharmaceutical
consultancy group, offering a range of services designed to
assist clients in achieving extraordinary growth across the
product and technology value chain, through three divisions:
Bridgehead Consulting - international consultants in
healthcare in areas of product strategy, business
development, due diligence and valuation
Healthcare Education Services - specialists in the
developments of global, regional and national integrated
programs for the pharmaceutical industry in medical
education, professional relations and medical
communications
Pharmalicensing - the leading online business tool for
biopharma dealmakers providing access to partner services,
intelligence databases and business reports
Press Releases
(21st May 2007) Bridgehead International has been honoured with The Queen's Award for Enterprise 2007, in the International Trade section, for outstanding achievement in international trade More
(15th Jan 2007) York, UK, 15 Jan 2006 - Pharmaceutical research and development in China is being constantly accelerated by successful clinical trials, a growing number of established R&D specialist companies and scientific technical expertise. More
(6th Jun 2006) Pharmalicensing launches revised versions of its Deals Briefings with up-to-date data More
(15th May 2006) New edition of report on opportunities in Indian pharma and biotech features partnering opportunities in companies, life science research institutes and biotech parks More
(27th Apr 2006) Partneringdesk Deals and Alliances therapy reports are revised with up-to-date deals More
Bridgehead International provides Experts' Report for listing of AGI Therapeutics plc on AIM and IEX
(27th Feb 2006) AGI Therapeutics plc, announced its admission to trading on AIM and IEX in a €42.5 Million (£29.2 million) Placing on 27 February 2006, which was arranged by Davy. More
(21st Feb 2006) New edition of Partneringreview summarizes pharma and biotech deals of 2005 More
(1st Feb 2006) Intercytex Group plc announced on 1st February 2006 that it had successfully completed an initial public offering on the AIM market of the London Stock Exchange, raising £15 million. More
(7th Dec 2005) Lombard Medical Technologies PLC, a developer of stent grafts and other medical products, announced on 7th December 2005 that it had successfully completed an initial public offering on the AIM market of the London Stock Exchange More
(9th Nov 2005) New summary from Partneringdesk highlights trends in dealmaking from the top pharma and biotech companies More
(11th Oct 2004) Worldwide Business Research and Pharmalicensing jointly awarded Endo Pharmaceuticals and Vernalis the BioBusiness Network Innovative Partnership 2004 award at BioBusiness Network 2004 in Geneva, Switzerland More
(6th Feb 2004) As part of the integration of Healthcare, a new Group name, Bridgehead International Ltd, will be adopted. More
(30th Dec 2003) The Bridgehead Pharmalicensing Group has announced that with effect from 1st January 2004, Dr David Stone joins the company as Non-Executive Chairman and that Tim Fitzgerald has been appointed Chief Executive Officer. More
(10th Dec 2003) The report, by Pharmalicensing founder Steve Poile and Head of Publishing Suzanne Elvidge, is an in-depth review of licensing structures and strategies for discovery and preclinical deals, supported with case studies and deals data analysis. More
(15th Sep 2003) Lead author of this new report, Paul Ranson puts all his practical experience and wisdom in front of the reader in an essential 'how to' book for business executives in the pharmaceutical industry but also those in medical devices and biotechnology. More
(9th May 2003) A new and unique service providing strategic and licensing support to biopharmaceutical and medical companies More
Head office
Bridgehead International Limited
Pera Innovation Park
Nottingham Road
Melton Mowbray
Leicestershire
LE13 0PB
United Kingdom
Tel: +44 1664 503 700
Fax: +44 1664 503 705
www | email
Pera Innovation Park
Nottingham Road
Melton Mowbray
Leicestershire
LE13 0PB
United Kingdom
Tel: +44 1664 503 700
Fax: +44 1664 503 705
www | email
Contact details
David Alcraft
Director
Director
Company figures
Formed: 2003
Number of employees: 45
Number of employees: 45
Regional and subsidiary offices
Bridgehead International - Princeton office
116 Village Blvd, Suite 200
Princeton
New Jersey
NJ 08540
New Jersey
Tel: +1 609 951-2202
Fax: +1 609 520-1702
www | email
116 Village Blvd, Suite 200
Princeton
New Jersey
NJ 08540
New Jersey
Tel: +1 609 951-2202
Fax: +1 609 520-1702
www | email
Pharmalicensing
Marlborough House, 1st Floor
Westminster PLace
York Business Park
Yok
North Yorkshire
YO26 6RW
United Kingdom
Tel: +44 1904 520460
Fax: +44 1904 520461
www | email
Marlborough House, 1st Floor
Westminster PLace
York Business Park
Yok
North Yorkshire
YO26 6RW
United Kingdom
Tel: +44 1904 520460
Fax: +44 1904 520461
www | email
Related categories
- Industry sector
- Business services
- Communications
- Consultancy
© Copyright 1995-2008 Pharmalicensing Ltd, is a division of 
All rights reserved. Terms and Conditions | Site map | Contact us